Kerry Group
Irish maker of taste, flavor, and nutrition ingredients supplying global food and drink brands.
Kerry keeps growing volumes and margins on long-standing customer contracts while bigger flavor and ingredient rivals compete for the same deals, with no sign yet of customers leaving.
Kerry Group sells ingredients like flavors, colors, and nutritional additives to large food and beverage makers around the world. It is hard to replace because customers have spent years working with Kerry's scientists to develop custom products, regulators require expensive approvals to switch suppliers, and Kerry's recipes are kept secret. The company grows slowly (around 3 percent per year by volume) but makes steady profits and cash. The real question is not survival but returns: competitors like Givaudan and IFF are also using AI tools to speed up product development, so if they start winning more customers because they can invent new flavors faster, Kerry's growth could flatten further or its prices could get squeezed.
Givaudan or IFF report faster new-product or volume growth than Kerry for two straight years. Would show AI-driven R&D speed at rivals is starting to take share from Kerry.
Kerry misses its Accelerate 2.0 target of €100m savings by 2028 in interim updates. Would show cost-efficiency program underdelivering, pressuring margins.
- FY2025 revenue €6.93 billion, continuing operations
- 3.0% group volume growth, 7.5% constant-currency EPS growth
- Americas region: €3.67 billion revenue, 3.8% volume growth
- Net debt/EBITDA rose to 1.9x from 1.6x in 2024 while buybacks continue.
- 2026 EPS guidance of 6-10% came in below prior ~9% analyst consensus, triggering a 5% share drop.
- Remaining 30% dairy divestment stake tied to 2030-2035 call/put options creates long structural uncertainty.
- Sector-wide fragrance antitrust investigations against peers could tighten regulatory scrutiny across the industry.
- Mature market growth (~3% volumes) limits upside versus faster-growing challengers.
| Rival | Direction | Evidence |
|---|---|---|
| Givaudan | contesting | Both named top-tier taste/nutrition players; Givaudan faces UK CMA fragrance price-fixing probe as of March 2026, Kerry does not |
| IFF | contesting | IFF named in US antitrust class action over fragrance pricing (2026), Kerry not implicated as of March 2026 |
| DSM-Firmenich | contesting | Under same UK CMA and US antitrust scrutiny as of 2026; Kerry avoids this regulatory overhang |
| Symrise | contesting | Also named in fragrance price-fixing probes as of March 2026, unlike Kerry |
| ADM and Cargill | contesting | Named alongside Kerry as top specialty food ingredients players in market research reports, no direct share-loss evidence |
- Is Kerry Group profitable in 2026?
- Yes. Kerry Group reported FY2025 continuing-operations revenue of about €6.93 billion with 3.0% volume growth, 80 bps EBITDA margin expansion, and 7.5% constant-currency adjusted EPS growth, per its 17 February 2026 preliminary results statement.
- Could AI replace Kerry Group's ingredient scientists?
- Unlikely soon. Kerry says its own tool KerryKalaido speeds recipe ideation from weeks to days or hours (vendor-claimed, July 2025), but physical manufacturing, food-safety certification, and decades of formulation IP remain outside AI's reach, keeping human R&D and regulatory teams central.
- Who is Kerry Group's biggest competitor?
- Kerry competes with Givaudan, IFF, DSM-Firmenich, ADM, Cargill and Symrise in taste and nutrition ingredients. Unlike several of these peers, Kerry is not named in the ongoing UK CMA and US antitrust fragrance price-fixing probes active as of March 2026.
- Who owns Kerry Group?
- Kerry Group plc is publicly listed on Euronext Dublin (KRZ) and the London Stock Exchange (KYGA). Following the 2024-2025 dairy divestment to the Co-Op, the Co-Op's direct member shareholding in Kerry rose from about 20% to 30%, per a January 2026 investor update.
- Why did Kerry Group stock fall in February 2026?
- Kerry shares dropped more than 5% on 17 February 2026 after second-half EBITDA missed consensus by about 3% and 2026 EPS guidance of 6-10% came in below the roughly 9% analyst estimate, despite the company launching a €300 million buyback the same day.
- How much debt does Kerry Group carry?
- Kerry's net debt rose to about €2.2 billion, pushing net debt to EBITDA to 1.9x as of the 17 February 2026 FY2025 results, up from 1.6x in 2024, a trend to watch given its concurrent €300 million share buyback.
- 2026-05-18Divested dairy unit rebrands as Kinisla, unveils €300m investment programme under Co-Op
- 2026-02-17FY2025 results: €6.93bn revenue, 3.0% volume growth, shares fall 5% on soft 2026 guidance
- 2026-01-14Q1 2026 investor update: 3.1% volume growth, EPS guidance maintained
- 2025-11Kerry acquires Bethlehem, Pennsylvania facility to expand coffee roasting capacity
- 2025-09Kerry launches Smart Taste toolset for sugar reduction and cost pressure
- 2025-02-17Kerry opens Digital Centre of Excellence at Naas, backed by €7.5m Enterprise Ireland grant
- 2025-01-02First phase of dairy sale to Co-Op completed, 70% stake for €350m
- 2024-11-12Kerry agrees to sell Kerry Dairy Ireland to Co-Op for ~€500m enterprise value
- History
- Kerry Group (2026-06-15)
- Kerry to sell Kerry Dairy Ireland in B2B shift (2024-11-12)
- Kerry Group completes first phase of €500m dairy business sale to co-op (2025-01-02)
- Kerry Dairy Ireland becomes Kinisla (2026-05-18)
- gurufocus.com (2026-07-24)
- Kerry Group plc (KYGA) Earnings Dates, Call Summary & Reports (2026-07-01)
- Preliminary Statement of Results 31 December 2025 (2026-02-17)
- Kerry Group FY2025 presentation (2026-02-17)
- Kerry Group cuts 2026 EPS outlook, misses EBITDA; shares down 5% (2026-02-17)
- Kerry Group (KRZ) Investor Update Summary (2026-01-14)
- KRZ Number of Employees